David Grossman
Stock Analyst at Stifel
(3.95)
# 653
Out of 4,761 analysts
154
Total ratings
60.95%
Success rate
7.23%
Average return
Main Sectors:
Stocks Rated by David Grossman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMWL American Well | Maintains: Hold | $9 → $10 | $11.74 | -14.82% | 2 | Feb 13, 2025 | |
| ACCD Accolade | Downgrades: Hold | $8 → $7.03 | $6.93 | +1.44% | 6 | Jan 9, 2025 | |
| VEEV Veeva Systems | Maintains: Buy | $240 → $272 | $225.79 | +20.47% | 7 | Dec 6, 2024 | |
| OPRX OptimizeRx | Maintains: Buy | $13 → $8 | $5.78 | +38.41% | 6 | Nov 14, 2024 | |
| IBM International Business Machines | Maintains: Buy | $205 → $246 | $261.48 | -5.92% | 20 | Oct 16, 2024 | |
| PAYX Paychex | Maintains: Hold | $130 → $141 | $148.51 | -5.06% | 9 | Oct 2, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $16 → $9 | $11.51 | -21.81% | 10 | Aug 1, 2024 | |
| ADP Automatic Data Processing | Maintains: Hold | $271 → $287 | $310.76 | -7.65% | 10 | Aug 1, 2024 | |
| DH Definitive Healthcare | Maintains: Buy | $9.5 → $7.5 | $4.92 | +52.44% | 3 | Jul 31, 2024 | |
| ACN Accenture | Maintains: Buy | $395 → $340 | $364.26 | -6.66% | 25 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $21 → $19 | $19.56 | -2.86% | 10 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6.5 | $4.79 | +35.70% | 8 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $0.69 | +479.71% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $117 → $121 | $66.51 | +81.93% | 11 | Feb 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $288 → $301 | $208.84 | +44.13% | 11 | Feb 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $12 | $5.23 | +129.45% | 4 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Positive | $22 → $29 | $21.17 | +36.99% | 9 | Jan 10, 2022 |
American Well
Feb 13, 2025
Maintains: Hold
Price Target: $9 → $10
Current: $11.74
Upside: -14.82%
Accolade
Jan 9, 2025
Downgrades: Hold
Price Target: $8 → $7.03
Current: $6.93
Upside: +1.44%
Veeva Systems
Dec 6, 2024
Maintains: Buy
Price Target: $240 → $272
Current: $225.79
Upside: +20.47%
OptimizeRx
Nov 14, 2024
Maintains: Buy
Price Target: $13 → $8
Current: $5.78
Upside: +38.41%
International Business Machines
Oct 16, 2024
Maintains: Buy
Price Target: $205 → $246
Current: $261.48
Upside: -5.92%
Paychex
Oct 2, 2024
Maintains: Hold
Price Target: $130 → $141
Current: $148.51
Upside: -5.06%
Teladoc Health
Aug 1, 2024
Maintains: Hold
Price Target: $16 → $9
Current: $11.51
Upside: -21.81%
Automatic Data Processing
Aug 1, 2024
Maintains: Hold
Price Target: $271 → $287
Current: $310.76
Upside: -7.65%
Definitive Healthcare
Jul 31, 2024
Maintains: Buy
Price Target: $9.5 → $7.5
Current: $4.92
Upside: +52.44%
Accenture
Jun 12, 2024
Maintains: Buy
Price Target: $395 → $340
Current: $364.26
Upside: -6.66%
May 17, 2024
Maintains: Hold
Price Target: $21 → $19
Current: $19.56
Upside: -2.86%
Apr 30, 2024
Maintains: Buy
Price Target: $8 → $6.5
Current: $4.79
Upside: +35.70%
Apr 1, 2024
Maintains: Buy
Price Target: $4
Current: $0.69
Upside: +479.71%
Feb 16, 2024
Maintains: Buy
Price Target: $117 → $121
Current: $66.51
Upside: +81.93%
Feb 12, 2024
Maintains: Buy
Price Target: $288 → $301
Current: $208.84
Upside: +44.13%
Nov 1, 2023
Maintains: Hold
Price Target: $15 → $12
Current: $5.23
Upside: +129.45%
Jan 10, 2022
Upgrades: Positive
Price Target: $22 → $29
Current: $21.17
Upside: +36.99%